252 results on '"Belda-Iniesta, C."'
Search Results
2. Integral nutritional approach to the care of cancer patients: results from a Delphi panel
3. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation
4. A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
5. Checkpoint kinase 1 modulates sensitivity to cisplatin after spindle checkpoint activation in SW620 cells
6. Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
7. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer
8. Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
9. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer
10. Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
11. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer
12. A critical role for choline kinase-α in the aggressiveness of bladder carcinomas
13. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy
14. Molecular markers in colorectal cancer: genetic bases for a customised treatment
15. New screening method for lung cancer by detecting volatile organic compounds in breath
16. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
17. Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium
18. Cáncer de pulmón (II). Tratamiento médico
19. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells
20. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells
21. New insights in β-tubulin sequence analysis in non-small cell lung cancer
22. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation
23. OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study
24. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation
25. Protocolo diagnóstico y terapéutico de la toxicidad aguda por radioterapia
26. Vesicle-mediated control of cell function: The role of extracellular matrix and microenvironment
27. Extracellular vesicles compartment in liquid biopsies: Clinical application
28. Extracellular vesicles compartment in liquid biopsies: Clinical application
29. Vesicle-mediated control of cell function: The role of extracellular matrix and microenvironment
30. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O(6)-Methylguanine-DNA Methyltransferase Biomarker Analyses
31. The Use of Peripheral Extracellular Vesicles for Identification of Molecular Biomarkers in a Solid Tumor Mouse Model
32. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients
33. The Use of Peripheral Extracellular Vesicles for Identification of Molecular Biomarkers in a Solid Tumor Mouse Model
34. Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study
35. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients
36. Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media
37. SOX2+ cell population from normal human brain white matter is able to generate mature oligodendrocytes
38. Engineering Iron Oxide Nanoparticles for Clinical Settings
39. Engineering Iron Oxide Nanoparticles for Clinical Settings
40. SOX2+ cell population from normal human brain white matter is able to generate mature oligodendrocytes
41. ET-12 * PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
42. Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC)
43. Identification of drug-sensitive prediction genes by an epigenetic reactivation screen of cisplatin-resistant NSCLC cell lines
44. EP-1385: Hypofraccionated stereotactic reirradiation with Novalis linac in patients with high-grade gliomas
45. Do β-tubulin pseudogenes really matter?
46. Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
47. PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain
48. PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain
49. PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in Spain
50. Foot pain: uncommon presentation of lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.